Pankaj Ramanbhai Patel

This inventor holds 23 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 18 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Cadila Healthcare Limited, Council of Scientific and Industrial Research. Active years: 2006-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pankaj Ramanbhai Patel. Retrieved from https://idiyas.com/inventor/pankaj-ramanbhai-patel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 14)

% Patents Active = 26.1

CIPO Patents = 2

EPO Patents = 18 (Patent Applications = 19)

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 44(Granted Patents)

Location History:

Ahmedadabad, IN (2012)
Ahmedabad, IN (2011 - 2016)
Gujarat, IN (2006 - 2022)

Company Filing History:

22 out of 131

Cadila Healthcare Limited

patents

1 out of 2,130

Council of Scientific and Industrial Research

patents

Years Active: 2006-2022

Loading Chart...

Areas of Expertise:

Primary Biliary Cholangitis

Lipodystrophy

Nonalcoholic Fatty Liver Disease

Poly (ADP-Ribose) Polymerase

Janus Kinase

Glucagon Antagonist

Antidiabetic Compounds

Glucokinase Activators

Peptide Expression

Rabies Virus Adaptation

Factor Xa Inhibitors

Inhalation Device

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11433050 - Treatment for primary biliary cholangitis (2022-09-06),

2. 10017470 - Treatment for lipodystrophy (2018-07-10),

3. 9908790 - Household solar still with easy operation and maintenance and enhanced output (2018-03-06),

4. 9814697 - Composition for nonalcoholic fatty liver disease (NAFLD) (2017-11-14),

5. 9783495 - Treatment for lipodystrophy (2017-10-10),

6. 9598418 - Substituted phthalazin-1 (2H)-one derivatives as selective inhibitors of poly (ADP-ribose) polymerase-1 (2017-03-21),

7. 9556148 - N-cyanomethylamides as inhibitors of janus kinase (2017-01-31),

8. 9433620 - Pharmaceutical compositions of lurasidone (2016-09-06),

9. 9394300 - Quinolone derivatives (2016-07-19),

10. 8883963 - Peptidomimetics with glucagon antagonistic and GLP 1 agonistic activities (2014-11-11),

11. 8841413 - Antidiabetic compounds (2014-09-23),

12. 8835469 - Substituted benzamide derivatives as glucokinase (GK) activators (2014-09-16),

13. 8507221 - Process for the expression of peptides of interest using GCSF as a fusion partner (2013-08-13),

14. 8492120 - Process for preparing human G-CSF (2013-07-23),

15. 8420851 - Selective TR-β 1 agonist (2013-04-16),

Title: Pankaj Ramanbhai Patel: A Pioneer in Pharmaceutical Innovations

Introduction

Pankaj Ramanbhai Patel, based in Ahmedabad, India, is a prominent inventor known for his significant contributions to the pharmaceutical industry. With an impressive portfolio of 23 patents, he has made remarkable strides in the areas of treatment for chronic diseases. His innovations play a critical role in addressing unmet medical needs.

Latest Patents

Among his latest inventions, Patel has developed a therapeutic compound for the treatment of primary biliary cholangitis (PBC). This invention offers a pharmaceutical composition that comprises a compound of Formula (I) or a pharmaceutically acceptable salt thereof, specifically designed for the prevention and treatment of PBC. Another notable patent addresses lipodystrophy, providing a therapeutic compound formulated to prevent and treat the condition, particularly in patients suffering from HIV infection or those undergoing combination therapy. This innovation targets the neutralization of lipohypertrophy, lipoatrophy, and metabolic abnormalities in patients.

Career Highlights

Pankaj Ramanbhai Patel has garnered extensive experience in the pharmaceutical sector, having worked with reputable organizations such as Cadila Healthcare Limited and the Council of Scientific & Industrial Research. His tenure in these companies has allowed him to translate his research insights into practical applications that benefit patients worldwide.

Collaborations

Throughout his career, Patel has collaborated with esteemed colleagues, including Mukul R Jain and Ranjit C Desai. These partnerships underscore the collaborative nature of his work, fostering innovation through shared expertise and knowledge.

Conclusion

Pankaj Ramanbhai Patel exemplifies the spirit of innovation in the pharmaceutical field. His commitment to developing effective treatments not only showcases his expertise as an inventor but also highlights the importance of research and collaboration in solving complex health issues. With numerous patents to his name, Patel is undoubtedly a valuable asset to the medical and scientific communities.

Profile summary based on public USPTO records.